Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;100:79-87
Published online before print November 16, 2006, doi: 10.1161/01.RES.0000253094.03023.3f
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
100/1/79    most recent
01.RES.0000253094.03023.3fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, W.
Right arrow Articles by Humar, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, W.
Right arrow Articles by Humar, R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*L-SERINE
Related Collections
Right arrow Angiogenesis
Right arrow Cell signalling/signal transduction
Right arrow Ischemic biology - basic studies
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide
(Circulation Research. 2007;100:79.)
© 2007 American Heart Association, Inc.


Molecular Medicine

Hypoxia-Induced Endothelial Proliferation Requires Both mTORC1 and mTORC2

Weimin Li*, Marco Petrimpol*, Klaus D. Molle, Michael N. Hall, Edouard J. Battegay, Rok Humar

From the Departments of Research (W.L., M.P., E.J.B., R.J.) and Internal Medicine (E.J.B.), University of Basel; and Department of Biochemistry (K.D.M., M.N.H.), Biocenter, University of Basel, Switzerland. Current address for W.L.: National Cancer Institute, Mouse Cancer Genetic Program, Frederick, Md.

Correspondence to Rok Humar, PhD, Department of Research, University Hospital Basel, Hebelstrasse 20, CH-4031 Basel, Switzerland. E-mail Rok.Humar{at}unibas.ch

A central regulator of cell growth that has been implicated in responses to stress such as hypoxia is mTOR (mammalian Target Of Rapamycin). We have shown previously that mTOR is required for angiogenesis in vitro and endothelial cell proliferation in response to hypoxia. Here we have investigated mTOR-associated signaling components under hypoxia and their effects on cell proliferation in rat aortic endothelial cells (RAECs). Hypoxia (1% O2) rapidly (>30 minutes) and in a concentration-dependent manner promoted rapamycin-sensitive and sustained phosphorylation of mTOR-Ser2448 followed by nuclear translocation in RAECs. Similarly, hypoxia induced phosphorylation of the mTORC2 substrate Akt-Ser473 (3 to 6 hours at 1% O2) and a brief phosphorylation peak of the mTORC1 substrate S6 kinase–Thr389 (10 to 60 minutes). Phosphorylation of Akt was inhibited by mTOR knockdown and partially with rapamycin. mTOR knockdown, rapamycin, or Akt inhibition specifically and significantly inhibited proliferation of serum-starved RAECs under hypoxia (P<0.05; n≥4). Similarly, hypoxia induced Akt-dependent and rapamycin-sensitive proliferation in mouse embryonic fibroblasts. This response was partially blunted by hypoxia-inducible factor-1{alpha} knockdown and not affected by TSC2 knockout. Finally, mTORC2 inhibition by rictor silencing, especially (P<0.001; n=7), and mTORC1 inhibition by raptor silencing, partially (P<0.05; n=7), inhibited hypoxia-induced RAEC proliferation. Thus, mTOR mediates an early response to hypoxia via mTORC1 followed by mTORC2, promoting endothelial proliferation mainly via Akt signaling. mTORC1 and especially mTORC2 might therefore play important roles in diseases associated with hypoxia and altered angiogenesis.


Key Words: hypoxia • mTORC1 • mTORC2 • S6K1 • Akt • proliferation • endothelial




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
R. Marone, D. Erhart, A. C. Mertz, T. Bohnacker, C. Schnell, V. Cmiljanovic, F. Stauffer, C. Garcia-Echeverria, B. Giese, S.-M. Maira, et al.
Targeting Melanoma with Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitors
Mol. Cancer Res., April 1, 2009; 7(4): 601 - 613.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
C.-Y. Wang, H.-H. Kim, Y. Hiroi, N. Sawada, S. Salomone, L. E. Benjamin, K. Walsh, M. A. Moskowitz, and J. K. Liao
Obesity Increases Vascular Senescence and Susceptibility to Ischemic Injury Through Chronic Activation of Akt and mTOR
Sci. Signal., March 17, 2009; 2(62): ra11 - ra11.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Li, S. Kotoshiba, C. Berthet, M. B. Hilton, and P. Kaldis
Rb/Cdk2/Cdk4 triple mutant mice elicit an alternative mechanism for regulation of the G1/S transition
PNAS, January 13, 2009; 106(2): 486 - 491.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Sanchez de Miguel, S. Neysari, S. Jakob, M. Petrimpol, N. Butz, A. Banfi, C. E. Zaugg, R. Humar, and E. J. Battegay
B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart
Cardiovasc Res, October 1, 2008; 80(1): 106 - 113.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. R. Schnell, F. Stauffer, P. R. Allegrini, T. O'Reilly, P. M.J. McSheehy, C. Dartois, M. Stumm, R. Cozens, A. Littlewood-Evans, C. Garcia-Echeverria, et al.
Effects of the Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 on the Tumor Vasculature: Implications for Clinical Imaging
Cancer Res., August 15, 2008; 68(16): 6598 - 6607.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Eyries, G. Siegfried, M. Ciumas, K. Montagne, M. Agrapart, F. Lebrin, and F. Soubrier
Hypoxia-Induced Apelin Expression Regulates Endothelial Cell Proliferation and Regenerative Angiogenesis
Circ. Res., August 15, 2008; 103(4): 432 - 440.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. C. McDonald, A. Oloumi, J. Mills, I. Dobreva, M. Maidan, V. Gray, E. D. Wederell, M. B. Bally, L. J. Foster, and S. Dedhar
Rictor and Integrin-Linked Kinase Interact and Regulate Akt Phosphorylation and Cancer Cell Survival
Cancer Res., March 15, 2008; 68(6): 1618 - 1624.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. T. Jindra, Y.-P. Jin, E. Rozengurt, and E. F. Reed
HLA Class I Antibody-Mediated Endothelial Cell Proliferation via the mTOR Pathway
J. Immunol., February 15, 2008; 180(4): 2357 - 2366.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Zhang, N. Honbo, E. J. Goetzl, K. Chatterjee, J. S. Karliner, and M. O. Gray
Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3150 - H3158.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
V. C. Munk, L. Sanchez de Miguel, M. Petrimpol, N. Butz, A. Banfi, U. Eriksson, L. Hein, R. Humar, and E. J. Battegay
Angiotensin II Induces Angiogenesis in the Hypoxic Adult Mouse Heart In Vitro Through an AT2-B2 Receptor Pathway
Hypertension, May 1, 2007; 49(5): 1178 - 1185.
[Abstract] [Full Text] [PDF]